Evaxion Biotech A/S(EVAX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

EVAX Evaxion Biotech A/S

Market Closed 01-16 16:00:00 EST

4.55

-0.24

-5.01%

盘后4.55

+0.000.00%

18:38 EST

High4.82	Low4.37	Vol94.17K
Open4.75	D1 Closing4.79	Amplitude9.46%
Mkt Cap37.78M	Tradable Cap25.17M	Total Shares8.30M
T/O433.87K	T/O Rate1.70%	Tradable Shares5.53M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"EVAX","market":"US","secType":"STK","nameCN":"Evaxion Biotech A/S","latestPrice":4.55,"timestamp":1768597200000,"preClose":4.79,"halted":0,"volume":94172,"hourTrading":{"tag":"盘后","latestPrice":4.55,"preClose":4.55,"latestTime":"18:38 EST","volume":16,"amount":71.293,"timestamp":1768606737166},"delay":0,"floatShares":5531900,"shares":8302700,"eps":-1.167371,"marketStatus":"Market Closed","change":-0.24,"latestTime":"01-16 16:00:00 EST","open":4.75,"high":4.8233,"low":4.37,"amount":433874.9546404,"amplitude":0.094635,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.167371,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1768899600000},"marketStatusCode":7,"adr":0,"adrRate":50,"listingDate":1612501200000,"exchange":"NASDAQ","adjPreClose":4.79,"postHourTrading":{"tag":"盘后","latestPrice":4.55,"preClose":4.55,"latestTime":"18:38 EST","volume":16,"amount":71.293,"timestamp":1768606737166},"volumeRatio":2.2986609053161744,"impliedVol":2.1042,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/EVAX/wiki","defaultTab":"wiki","newsList":[{"id":"2603680652","title":"Lake Street Sticks to Its Buy Rating for Evaxion Biotech (EVAX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2603680652","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603680652?lang=en_us&edition=fundamental","pubTime":"2026-01-13 22:16","pubTimestamp":1768313796,"startTime":"0","endTime":"0","summary":"In a report released today, Thomas Flaten from Lake Street maintained a Buy rating on Evaxion Biotech, with a price target of $11.00. According to ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/lake-street-sticks-to-its-buy-rating-for-evaxion-biotech-evax-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/lake-street-sticks-to-its-buy-rating-for-evaxion-biotech-evax-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EVAX"],"gpt_icon":0},{"id":"2603817906","title":"Evaxion A/S Announces Expansion of AI-Immunology™ Platform Into Autoimmune Diseases and Outlines 2026 Milestones Including Biomarker Data, Clinical Efficacy Results, and Pipeline Advancements","url":"https://stock-news.laohu8.com/highlight/detail?id=2603817906","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603817906?lang=en_us&edition=fundamental","pubTime":"2026-01-13 21:00","pubTimestamp":1768309253,"startTime":"0","endTime":"0","summary":"Evaxion A/S Announces Expansion of AI-Immunology Platform Into Autoimmune Diseases and Outlines 2026 Milestones Including Biomarker Data, Clinical Efficacy Results, and Pipeline Advancements. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Evaxion A/S published the original content used to generate this news brief via GlobeNewswire  on January 13, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nNDL4qSPQC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","IE00B64PRP62.GBP","LU2210150020.SGD","BK4112","LU2210149790.SGD","BK4139","SG9999014013.SGD","IE00BGHQF748.EUR","EVAX","IE00B3QW5Z07.USD","IE00BKPKM429.USD","LU0314104364.USD","LU2095319765.USD","NDAQ","SG9999014005.SGD","BK4588","BK4585","SG9999014039.USD"],"gpt_icon":0},{"id":"2601803947","title":"Evaxion A/S to Present 2026 Milestones at Biotech Showcase Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2601803947","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601803947?lang=en_us&edition=fundamental","pubTime":"2026-01-07 21:00","pubTimestamp":1767790844,"startTime":"0","endTime":"0","summary":"Evaxion A/S, a clinical-stage TechBio company specializing in AI-powered vaccine development, will present its 2026 company milestones at the Biotech Showcase conference in San Francisco. CEO Helen Tayton-Martin is scheduled to provide a company update on January 13, 2026, at 2:00pm PST in the Yosemite C track . The event coincides with the J.P. Morgan Healthcare Conference, and Evaxion will engage with stakeholders and potential business partners throughout the week.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Evaxion A/S published the original content used to generate this news brief via GlobeNewswire  on January 07, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260107:nNDL4kZvvz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0787776722.HKD","LU2552382215.SGD","LU1548497426.USD","LU0267386448.USD","BK4112","LU2106854487.HKD","LU0211326839.USD","LU2592432038.USD","LU0417517546.SGD","LU1551013342.USD","EVAX","IE0034235295.USD","LU2211815571.USD","LU2505996681.GBP","LU2023250504.SGD","LU1162221912.USD","LU0943347566.SGD","LU1267930490.SGD","BK4207","LU0211327993.USD","LU2456880835.USD","LU0234572021.USD","LU1244550577.SGD","LU0106831901.USD","IE00BWXC8680.SGD","IE00BDRTCR15.USD","LU0345770993.USD","LU0265550946.USD","LU1261432733.SGD","LU2552382058.USD","BK4588","BK4504","LU0170899867.USD","LU2237443465.HKD","LU0048584097.USD","LU2023250843.SGD","LU2095319765.USD","LU1974910355.USD","IE00B64PRP62.GBP","IE00BKVL7J92.USD","IE0034235303.USD","LU2054465674.USD","LU0496365809.HKD","LU1363072403.SGD","IE00BKDWB100.SGD","LU1032466523.USD","LU2746668974.SGD","NDAQ","IE00BJLML261.HKD","IE00BLSP4239.USD"],"gpt_icon":0},{"id":"2594367297","title":"European Equities Traded in the US as American Depositary Receipts Little Changed in Friday Trading; Gains 2% for Week","url":"https://stock-news.laohu8.com/highlight/detail?id=2594367297","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2594367297?lang=en_us&edition=fundamental","pubTime":"2025-12-27 00:07","pubTimestamp":1766765233,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were little changed late Friday morning, edging 0.07% higher to 1,689.69 on the S&P Europe Select ADR Index, which has risen 2% for t","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0320765992.SGD","NCNA","BK4107","SNN","BK7511","CLLS","LU0300736492.USD","GRFS","BK4168","BK7095","NTZ","BK4585","BHP","BK4139","TRVG","LU1829250122.USD","CUK","LU2236285917.USD","LU2456880835.USD","AZN","BK4158","EVAX","BK4568","AMRN","BK4095","BK7119","LU2417539215.USD","ASND","LU0300736062.USD","LU0889565916.HKD","BK4007","BK4077","BDRX","BCYC","LU2462157665.USD","LU0109394709.USD","BK7507","BK4142","AFG","BHP.AU","BUD.AU","BK4082","BK4588","BUD","BK4117","EDAP"],"gpt_icon":0},{"id":"2592160651","title":"BUZZ-U.S. STOCKS ON THE MOVE-Intuitive Machines, Palo Alto Networks, Redwire","url":"https://stock-news.laohu8.com/highlight/detail?id=2592160651","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592160651?lang=en_us&edition=fundamental","pubTime":"2025-12-19 22:09","pubTimestamp":1766153366,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Intuitive Machines, Palo Alto Networks,RedwireEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nL6N3XP0LF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LMT","ETN","NVDS.UK","LYFT","NVDS","IE00BFXG0V08.USD","NVDY","LU1821325948.USD","NVIW.SI","LU1169589451.USD","WYFI","LU1868836914.USD","ACN","LU2756315664.SGD","PCAR","LU1868836591.USD","PANW","LUNR","MRK","NVDD","NVD2.UK","UUUU","3NVD.UK","NVDX","NVDU","BA","LU1868837136.USD","ALT","2NVD.UK","LU1691799644.USD","NVD3.UK","SNVD.UK","BK4535","NVD","IE0002141913.USD","RDW","LU2264538146.SGD","RIOT","EVAX","BTBT","AGCO"],"gpt_icon":1},{"id":"2592697401","title":"Evaxion a/S - Co Retains Global Rights to Evx-B2 and Will Look for Another Potential Licensing Partner","url":"https://stock-news.laohu8.com/highlight/detail?id=2592697401","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592697401?lang=en_us&edition=fundamental","pubTime":"2025-12-19 20:00","pubTimestamp":1766145601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nTUA7KZJCC:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EVAX","BK4139"],"gpt_icon":0},{"id":"2592697251","title":"Evaxion a/S - Msd Declines to Exercise Option for Evaxion's Gonorrhea Vaccine Candidate Evx-B2","url":"https://stock-news.laohu8.com/highlight/detail?id=2592697251","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592697251?lang=en_us&edition=fundamental","pubTime":"2025-12-19 20:00","pubTimestamp":1766145601,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nTUA7KZJCC:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EVAX","BK4139"],"gpt_icon":0},{"id":"2592169728","title":"Evaxion a/S - No Impact on Evaxion's Cash Runway Extending to Second Half of 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2592169728","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592169728?lang=en_us&edition=fundamental","pubTime":"2025-12-19 20:00","pubTimestamp":1766145601,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nTUA7KZJCC:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","EVAX"],"gpt_icon":0},{"id":"2592169724","title":"Evaxion a/S - Eligible for up to $592 Mln in Milestone Payments Associated With the Development of Evx-B3","url":"https://stock-news.laohu8.com/highlight/detail?id=2592169724","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592169724?lang=en_us&edition=fundamental","pubTime":"2025-12-19 20:00","pubTimestamp":1766145601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nTUA7KZJCC:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BLSP4239.USD","LU1917777945.USD","LU1037948897.HKD","SG9999001176.USD","BK4550","LU0965509010.AUD","SG9999014567.USD","IE00BN8TJ469.HKD","IE00BSNM7G36.USD","LU1035773651.USD","IE00BFTCPJ56.SGD","LU2468319806.SGD","LU1989772840.SGD","LU0203345920.USD","LU1585245621.USD","LU1941712264.USD","BK4588","LU1699723380.USD","SG9999002232.USD","LU1116320901.HKD","LU0006306889.USD","IE000M9KFDE8.USD","LU1066051811.HKD","LU2023250504.SGD","SG9999013999.USD","LU1066051498.USD","LU0985320562.USD","BK4533","LU0130517989.USD","LU1066051225.USD","LU1093756325.SGD","LU0070302665.USD","LU1934455863.HKD","LU2112291526.USD","BK4516","LU1974910355.USD","SG9999014559.SGD","LU2089984988.USD","LU1037948541.HKD","LU2125154935.USD","LU2324357040.USD","BK4559","LU0122379950.USD","LU0208291251.USD","LU1929549753.HKD","SG9999015358.SGD","SG9999014575.USD","LU0058720904.USD","LU1291159041.SGD","IE00B4R5TH58.HKD","LU0234572021.USD","LU1934455194.USD","LU1061106388.HKD","LU1989772923.USD","SGXZ57979304.SGD","LU1983299246.USD","BK4139","IE0009355771.USD","LU1941712348.USD","LU2361045086.USD","LU0265550359.USD","LU2361044865.SGD","LU1162221912.USD","LU1571399168.USD","LU0965509101.SGD","IE00BBT3K403.USD","LU0211331839.USD","LU1430594728.SGD","LU2106854487.HKD","BK4007","SG9999014542.SGD","IE0002141913.USD","LU0266013472.USD","LU2461242641.AUD","LU0238689110.USD","EVAX","IE00B2B36J28.USD","BK4534","IE00B1BXHZ80.USD","LU1093756168.USD","LU1066053197.SGD","LU1989771016.USD","LU0965509283.SGD","LU1934455277.USD","IE00BJT1NW94.SGD","LU0265550946.USD","SG9999001176.SGD","LU0106261372.USD","LU1057294990.SGD","LU0648001328.SGD","LU0098860793.USD","LU0861579265.USD","LU1116320737.USD","BK4585","IE00BLSP4452.SGD","LU2125154778.USD","LU0203347892.USD","LU0130102774.USD","SG9999001440.SGD","LU0289739699.SGD","LU0320765489.SGD","LU0965508806.USD","LU1201861249.SGD","LU2023250843.SGD","LU0477156953.USD","SG9999002224.SGD","LU0320765646.SGD","LU0980610538.SGD","SG9999015341.SGD","LU2360032135.SGD","LU2361044949.HKD","LU1069347547.HKD","IE00BJJMRZ35.SGD","LU1023059063.AUD"],"gpt_icon":0},{"id":"2592169171","title":"Evaxion Provides Update on Msd Collaboration - Retains Global Rights to Gonorrhea Vaccine Candidate Evx-B2","url":"https://stock-news.laohu8.com/highlight/detail?id=2592169171","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592169171?lang=en_us&edition=fundamental","pubTime":"2025-12-19 20:00","pubTimestamp":1766145601,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nTUA7KZJCC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EVAX","BK4139"],"gpt_icon":0},{"id":"2592169798","title":"Evaxion provides update on MSD collaboration - retains global rights to Gonorrhea vaccine candidate EVX-B2","url":"https://stock-news.laohu8.com/highlight/detail?id=2592169798","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592169798?lang=en_us&edition=fundamental","pubTime":"2025-12-19 20:00","pubTimestamp":1766145600,"startTime":"0","endTime":"0","summary":"MSD declines to exercise option for EVX-B2 developmentEvaxion is now able to out-license EVX-B2 to another partnerEvaxion maintains its strong belief in EVX-B2, which has shown to be protective agains","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/19/3208399/0/en/Evaxion-provides-update-on-MSD-collaboration-retains-global-rights-to-Gonorrhea-vaccine-candidate-EVX-B2.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EVAX","BK4023","BK4588","BK4585","AI","BK4139","BK4543","BK4528","BK4551","BK4587","EVX"],"gpt_icon":0},{"id":"2591628605","title":"European Equities Traded in the US as American Depositary Receipts Open Week Higher in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2591628605","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591628605?lang=en_us&edition=fundamental","pubTime":"2025-12-16 00:08","pubTimestamp":1765814936,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts kicked off the week higher late Monday morning, rising 0.57% to 1,657.92 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by brewing company Anheuser-Busch InBev  and lender Banco Santander , which advanced 2.3% and 1.5%, respectively. They were followed by lender Banco Bilbao Vizcaya Argentaria  and biopharmaceutical company DBV Technologies , which were up 0.7% and 0.5%, respectively.The decliners from continental Europe were led by biopharmaceutical company argenx  and biotech firm Evaxion , which fell 4.9% and 4.4%, respectively. They were followed by internet advertising firm Criteo  and Sequans Communications , which were down 3.1% and 2.2%, respectively.From the UK and Ireland, the gainers were led by biopharmaceutical company Biodexa Pharmaceuticals  and biotech firm Trinity Biotech , which rose 14% and 3.7%, respectively. They were followed by lender Barclays  and insurance compa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PUK","BCS","AMRN","BK4162","LU0084288595.USD","SAN","LU0109394709.USD","BCYC","BK4521","BK4207","IE00BFTCPJ56.SGD","BBVA","BDRX","IE00BJJMRZ35.SGD","AFG","BK4585","IE00B4R5TH58.HKD","BK4107","DAVA","SAN.AU","BK4139","BK4117","BK4505","BK4009","IE00BJT1NW94.SGD","BK4588","IE0034235188.USD","TRIB","LU0648005311.SGD","BK4082","IE0009355771.USD","LU1983260115.SGD","LU2324357040.USD","CRTO","LU0320765992.SGD","BK7119","IE0002141913.USD","IE00B2B36J28.USD","EVAX","SQNS","BK4158","DAVA.AU","LU0889565916.HKD","SNN","BUD.AU","BK4134","BUD","BK7142","DBVT","ARGX"],"gpt_icon":0},{"id":"2590510653","title":"European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2590510653","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590510653?lang=en_us&edition=fundamental","pubTime":"2025-12-12 00:10","pubTimestamp":1765469447,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were on the rise late Thursday morning, increasing 0.82% to 1,663.66 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biotech firm Evaxion  and biopharmaceutical firm Cellectis , which rose 4.6% and 3.9%, respectively. They were followed by telecommunications company Nokia  and pharmaceutical firm Novo Nordisk , which advanced 3.6% and 2.6% respectively.The decliners from continental Europe were led by semiconductor company Sequans Communications  and medical device maker EDAP TMS , which fell 3.8% and 1.7% respectively. They were followed by oil and gas company Eni  and petroleum refiner Equinor , which were off 0.2% each.From the UK and Ireland, the gainers were led by cruise line operator Carnival  and biopharmaceutical company Akari Therapeutics , which increased 4% and 3.4% respectively. They were followed by communications company WPP  and alcoholic beverage company Diageo , whic","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1093756168.USD","LU0154236417.USD","E","CUK","BK4599","WPP","BK4117","NCNA","NVO.AU","BK4139","CLLS","LU1093756325.SGD","EVAX","SQNS","BDRX","BK4585","BK4169","EDAP","BK4532","BK4141","EQNR","BK4007","IE00BZ1G4Q59.USD","BK4107","IE00BKVL7J92.USD","BK4142","BK4082","BCYC","BK7104","DGE.UK","BK4588","SNN","WPP.AU","BK4547","IE00BMPRXN33.USD","BK4201","BK4009","AKTX","BK4020","BK4559","IE00BMPRXR70.SGD","AFG","DEO","NOK"],"gpt_icon":1},{"id":"2590539837","title":"European Equities Traded in the US as American Depositary Receipts Trend Higher in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2590539837","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590539837?lang=en_us&edition=fundamental","pubTime":"2025-12-11 00:08","pubTimestamp":1765382894,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were heading higher late Wednesday morning, rising 0.67% to 1,636.27 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biopharmaceutical companies DBV Technologies  and Cellectis , which climbed 14% and 6.8%, respectively. They were followed by pharmaceutical company Novo Nordisk  and brewing company Anheuser-Busch InBev , which advanced 3.8% and 1.8%, respectively.The decliners from continental Europe were led by biotech firm Evaxion  and semiconductor company Sequans Communications , which fell 3.8% and 2.1%, respectively. They were followed by internet advertising firm Criteo  and medical device maker EDAP TMS , which were down 1.9% each.From the UK and Ireland, the gainers were led by biopharmaceutical company Biodexa Pharmaceuticals  and lender HSBC , which rose 33% and 4.1%, respectively. They were followed by biopharmaceutical company Bicycle Therapeutics  and educational publish","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AMRN","BK4521","BK4009","CRTO","BK4204","IE00BZ1G4Q59.USD","LU0154236417.USD","LU0052756011.USD","BK4141","BK4599","BK4111","EVAX","BK4007","LU0310800965.SGD","BK4107","CLLS","LU2236285917.USD","BK4207","SQNS","PSO","LU1093756168.USD","BK7104","BDRX","BK4588","BUD","LU1093756325.SGD","IE00BKVL7J92.USD","EDAP","BK4117","BK4585","BK4158","NCNA","BK4139","IE00BFMHRM44.USD","NVO","LU0128525689.USD","LU1267930227.SGD","AKTX","TRIB","DBVT","BCYC","BK7119","BK4532","HSBC","00005","BK4082"],"gpt_icon":1},{"id":"2590358352","title":"European Equities Traded in the US as ADRs Little Changed in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2590358352","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590358352?lang=en_us&edition=fundamental","pubTime":"2025-12-09 00:01","pubTimestamp":1765209714,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were little changed late Monday morning, easing less than 0.1% to 1,630.2 on the S&P Europe Select ADR Index.From continental Europe,","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4559","BK7095","BDRX","SNY","LU0154236417.USD","DBVT","BK4585","BK4546","BK4548","BK7104","UN","DGE.UK","SLN","AKTX","BK4168","BK4535","TRIB","ULVR.UK","BK4532","LU0124676726.USD","BK4551","IE00BZ1G4Q59.USD","MTLS","BK4139","IE00BKVL7J92.USD","BK4082","BK4592","EVAX","LU0300736492.USD","LU1093756168.USD","BK4183","UL","BK4023","EDAP","BK4007","BK4169","LU0300736062.USD","BK4568","AUTL","BK4588","BK4599","AMRN","BK7507","BNTX","DEO","BHP","LU1093756325.SGD","IE00BFXG1179.USD","BK7511","LU0689626769.HKD"],"gpt_icon":1},{"id":"2589533237","title":"Evaxion Unveils Promising Preclinical Data for Off-the-Shelf AML Vaccine EVX-04","url":"https://stock-news.laohu8.com/highlight/detail?id=2589533237","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589533237?lang=en_us&edition=fundamental","pubTime":"2025-12-08 19:19","pubTimestamp":1765192752,"startTime":"0","endTime":"0","summary":"Evaxion A/S has announced new preclinical data for its acute myeloid leukemia  vaccine candidate, EVX-04. The results were presented in an oral session at the American Society of Hematology  Annual Meeting and Exposition in Orlando, Florida. The data show that EVX-04, designed with Evaxion's proprietary AI-Immunology platform, induces strong specific T-cell responses and prevents tumor growth in preclinical models. EVX-04 targets multiple non-conventional endogenous retrovirus  tumor antigens and is developed as an off-the-shelf therapeutic cancer vaccine. According to the company, the off-the-shelf vaccine concept behind EVX-04 may also have potential applications in other hard-to-treat cancers.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nNDL8chL28:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EVAX","BK4139"],"gpt_icon":0},{"id":"2589821763","title":"Evaxion Unveils Promising Preclinical Data for AML Vaccine EVX-04 at ASH Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2589821763","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589821763?lang=en_us&edition=fundamental","pubTime":"2025-12-07 03:00","pubTimestamp":1765047615,"startTime":"0","endTime":"0","summary":"Evaxion A/S, a clinical-stage biotechnology company specializing in AI-powered immunology, has announced new preclinical data for its acute myeloid leukemia  vaccine candidate, EVX-04. The results, which demonstrate that EVX-04 triggers strong specific T-cell responses and effectively prevents tumor growth in preclinical models, were presented at the American Society of Hematology  Annual Meeting and Exposition in Orlando, Florida. EVX-04 is an off-the-shelf therapeutic cancer vaccine developed using Evaxion's proprietary AI-Immunology platform and targets non-conventional endogenous retrovirus  tumor antigens. The company indicates that the off-the-shelf vaccine concept underlying EVX-04 has potential applications across other hard-to-treat cancers.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251206:nNDL5HFgP4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","SG9999014013.SGD","BK4139","BK4112","EVAX","LU2210149790.SGD","LU2095319765.USD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","SG9999014005.SGD","BK4588","LU0314104364.USD","SG9999014021.USD","BK4585","NDAQ","IE00BKPKM429.USD"],"gpt_icon":0},{"id":"2586266977","title":"European Equities Traded in the US as American Depositary Receipts Surge in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2586266977","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586266977?lang=en_us&edition=fundamental","pubTime":"2025-11-27 00:03","pubTimestamp":1764172980,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were surging higher late Wednesday morning, rising 1.25% to 1,614.11 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by pharmaceutical companies Novo Nordisk  and Ascendis Pharma , which rose 3.5% and 1.8%, respectively. They were followed by biopharmaceutical company DBV Technologies  and lender Banco Santander , which were up 1.7% and 1.6%, respectively.The decliners from continental Europe were led by biopharmaceutical company Cellectis  and brewing company Anheuser-Busch InBev , which fell 4.6% and 1%, respectively. They were followed by biotech firm Evaxion  and pharmaceutical company Sanofi , which were off 0.9% each.From the UK and Ireland, the gainers were led by biopharmaceutical companies Akari Therapeutics  and NuCana , which increased 5.5% and 3.7%, respectively. They were followed by lenders Barclays  and Lloyds Banking Group , which advanced 3.2% each.The decliners from the","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4521","BCS","NVO.AU","IE00BZ1G4Q59.USD","ASND","BK4559","LU0154236417.USD","SAN.AU","BK4599","AFG","SNY","EVAX","LU0889565916.HKD","BK4007","BK4107","CLLS","IE00BFXG1179.USD","BK4207","LYG","SAN","LU1093756168.USD","BK7104","BK4588","DEO","BUD","LU1093756325.SGD","LU0320765992.SGD","IE00BKVL7J92.USD","BUD.AU","BK4169","BK4117","BK4585","BK4158","NCNA","BK4139","NVO","DGE.UK","LU0109394709.USD","MREO","AKTX","BK4505","DBVT","BCYC","BK7119","BK4532","AUTL","BK7142"],"gpt_icon":1},{"id":"2586562496","title":"European Equities Traded in the US as American Depositary Receipts Little Changed in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2586562496","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586562496?lang=en_us&edition=fundamental","pubTime":"2025-11-25 00:14","pubTimestamp":1764000859,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts opened the week little changed late Monday morning, edging 0.1% higher to 1,572.55 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biopharmaceutical company Cellectis  and internet browser company Opera , which advanced 10% and 2.4%, respectively. They were followed by medical device maker EDAP TMS  and telecommunications company Nokia , which increased 1.7% and 1.5%, respectively.The decliners from continental Europe were led by pharmaceutical company Novo Nordisk  and internet advertising firm Criteo , which fell 7.8% and 1.4%, respectively. They were followed by oil and gas company Eni , which was down 1%.From the UK and Ireland, the gainers were led by biopharmaceutical companies Mereo BioPharma Group  and Bicycle Therapeutics , which rose 3.6% each. They were followed by biotech firm Trinity Biotech  and biopharmaceutical company NuCana , which were up 3.2% and 1.7%, respectively","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4009","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","BK4208","MREO","BDRX","EDAP","BK4139","NVO.AU","BK4547","LU1093756168.USD","BK4082","LU1093756325.SGD","BK4505","BCYC","E","AFG","BK4107","BK4585","OPRA","IE00BMPRXR70.SGD","EVAX","BK4020","BK4201","BK4588","WPP.AU","BK7104","IE00BMPRXN33.USD","BK4117","LU0154236417.USD","NVO","BK4007","CRTO","BK4599","CLLS","WPP","IE00BFMHRM44.USD","AKTX","NCNA","BK4532","TRIB","NOK","BK4023","NGG"],"gpt_icon":1},{"id":"2585890142","title":"European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Down 3% for Week","url":"https://stock-news.laohu8.com/highlight/detail?id=2585890142","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585890142?lang=en_us&edition=fundamental","pubTime":"2025-11-22 00:01","pubTimestamp":1763740869,"startTime":"0","endTime":"0","summary":"Asian equities traded in the US as American depositary receipts were tracking higher Friday morning, rising 0.65% to 1,561.36 on the S&P Europe Select ADR Index, which is down close to 3% for  the wee","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4559","UL","BK4139","BK7119","AUTL","BK4142","DEO","BK4546","BUD","LU0006061336.USD","BCYC","AFG","BK4107","MTLS","BK4585","BK4158","OPRA","SQNS","BK4115","IHG","EVAX","LU2543165471.USD","LU0689626769.HKD","BK4588","BK4592","BUD.AU","SLN","BK4183","BK4117","BK4169","BK4141","BTI","UN","CLLS","TEF","BK4111","ULVR.UK","BTI.AU","BK4204","BK7062","DGE.UK","NCNA","LU0124676726.USD","PSO","BK4075","BK4023"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.evaxionbiotech.com","stockEarnings":[{"period":"1week","weight":-0.1043},{"period":"1month","weight":-0.2235},{"period":"3month","weight":-0.3299},{"period":"6month","weight":0.73},{"period":"1year","weight":0.3542},{"period":"ytd","weight":-0.0461}],"compareEarnings":[{"period":"1week","weight":-0.0035},{"period":"1month","weight":0.0302},{"period":"3month","weight":0.041},{"period":"6month","weight":0.1021},{"period":"1year","weight":0.1691},{"period":"ytd","weight":0.0143}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies for cancers, bacterial diseases, and viral infections. The company develops EVX-01, a cancer immunotherapy that is in clinical Phase IIb trial for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy that is in Phase IIa trial for adjuvant melanoma; and EVX-03, a DNA-based immunotherapy for the treatment of various cancers. Its programs also include EVX-B1, EVX-B2, and EVX-V1, which are vaccines that are in pre-clinical stage for the treatment of bacterial and viral diseases. The company was incorporated in 2008 and is headquartered in Hørsholm, Denmark.","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.254949},{"month":2,"riseRate":0,"avgChangeRate":-0.092268},{"month":3,"riseRate":0,"avgChangeRate":-0.116351},{"month":4,"riseRate":0.6,"avgChangeRate":0.075553},{"month":5,"riseRate":0.4,"avgChangeRate":0.067918},{"month":6,"riseRate":0.2,"avgChangeRate":-0.044814},{"month":7,"riseRate":0.4,"avgChangeRate":0.060856},{"month":8,"riseRate":0.6,"avgChangeRate":-0.04913},{"month":9,"riseRate":1,"avgChangeRate":0.19717},{"month":10,"riseRate":0.4,"avgChangeRate":0.102065},{"month":11,"riseRate":0.2,"avgChangeRate":-0.236379},{"month":12,"riseRate":0,"avgChangeRate":-0.21322}],"exchange":"NASDAQ","name":"Evaxion Biotech A/S","nameEN":"Evaxion Biotech A/S"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Evaxion Biotech A/S(EVAX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Evaxion Biotech A/S(EVAX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Evaxion Biotech A/S,EVAX,Evaxion Biotech A/S股票,Evaxion Biotech A/S股票老虎,Evaxion Biotech A/S股票老虎国际,Evaxion Biotech A/S行情,Evaxion Biotech A/S股票行情,Evaxion Biotech A/S股价,Evaxion Biotech A/S股市,Evaxion Biotech A/S股票价格,Evaxion Biotech A/S股票交易,Evaxion Biotech A/S股票购买,Evaxion Biotech A/S股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Evaxion Biotech A/S(EVAX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Evaxion Biotech A/S(EVAX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction